Background and Objectives
Generic drugs are generally used worldwide because of affordability compared to brand-name drugs. One of the main differences between brand-name and generic drugs is pharmaceutical excipients. We previously reported the effects of pharmaceutical excipients on the membrane permeation of drugs via the paracellular and transcellular routes, which are passive transport routes. P-glycoprotein (P-gp) is a typical ATP-binding cassette transporter and is mostly responsible for drug–drug interactions involving transporters. In the present study, rhodamine 123 (Rho123) was selected as the P-gp substrate, and the effects of pharmaceutical excipients on its membrane transport in the rat jejunum and ileum were examined.
Twenty major pharmaceutical excipients widely used in the pharmaceutical industry were selected. The in vitro diffusion chamber method using the rat jejunum and ileum was employed to investigate the effects of pharmaceutical excipients on the membrane permeation of Rho123.
The results obtained showed that the membrane permeability of Rho123 significantly (P < 0.05) changed under certain dosage conditions of pharmaceutical excipients such as sodium carboxymethyl starch, pullulan, glyceryl monostearate and so on. Furthermore, the effects of pharmaceutical excipients were site specific in the small intestine.
The present results demonstrated that some pharmaceutical excipients altered the membrane permeability of Rho123 in the rat small intestine.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Brady JM, Cherrington NJ, Hartley DP, Buist SC, Li N, Klaassen CD. Tissue distribution and chemical induction of multiple drug resistance genes in rats. Drug Metab Dispos. 2002;30:838–44.
Fujo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA. 1987;84:265–9.
Cordon-Cardo C, O’Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood–brain barrier sites. Proc Natl Acad Sci USA. 1989;86:695–8.
Lum BL, Gosland MP. Pharmacologic implications for the clinica; use of P-glycoprotein inhibitors. Hematol Oncol Clin N Am. 1995;9:319–36.
Russel FG, Masereeuw R, van Aubel RA. Molecular aspects of renal anionic drug transport. Annu Rev Physiol. 2002;64:563–94.
Szakács G, Váradi A, Ozvegy-Laczka C, Sarkadi B. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug Discov Today. 2008;13:379–93.
Hyde SC, Emsley P, Hartshorn MJ, Mimmack MM, Gileadi U, Pearce SR, Gallagher MP, Gill DR, Hubbard RE, Higgins CF. Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature. 1990;346:362–5.
Dean M, Hamon Y, Chimini GT. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res. 2001;42:1007–17.
Tomita M, Takizawa Y, Kishimoto H, Hayashi M. Assessment of ileal P-glycoprotein dysfunction induced by ischemia/reperfusion using in vivo animal model. Drug Metab Pharmacokinet. 2008;23:356–63.
Takizawa Y, Kishimoto H, Kitazato T, Tomita M, Hayashi M. Changes in the localization of ileal P-glycoprotein induced by intestinal ischemia/reperfusion. Biol Pharm Bull. 2011;34:408–14.
Iijima H, Kamei M, Koshimizu T, Shiragami M. Evaluation of information for generic drugs based on importance and necessity. Yakugaku Zasshi. 2005;125(9):739–47.
Onda M, Kanematsu M, Kitamura T, Sakai T, Sakagami K, Tanaka K, Hamahata Y, Hirooka T, Fujii K, Matsuda M, Miki H, Mashimo H, Hada R, Arakawa Y. Availability of drug information on bioequivalence of generic products-findings of graduate interns at a university pharmacy. Yakugaku Zasshi. 2007;127(7):1159–66.
Takizawa Y, Kishimoto H, Nakagawa M, Sakamoto N, Tobe Y, Furuya T, Tomita M, Hayashi M. Effects of pharmaceutical excipients on membrane permeability in rat small intestine. Int J Pharm. 2013;453:363–70.
Takizawa Y, Aizawa Y, Furuya T, Hayashi M. Influence of pharmaceutical excipients on membrane transport via transcellular route in rat small intestine. Sch Acad J Pharm. 2019;8(11):488–96.
Cornaire G, Woodley J, Hermann P, Cloarec A, Arellano C, Houin G. Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm. 2005;278:119–31.
Sawangrat K, Morishita M, Kusamori K, Katsumi H, Sakane T, Yamamoto A. Effects of various pharmaceutical excipients on the intestinal transport and absorption of Sulfasalazine, a typical substrate of breast cancer resistance protein transporter. J Pharm Sci. 2018;107(11):2946–56.
Sawangrat K, Yamashita S, Tanaka A, Morishita M, Kusamori K, Katsumi H, Sakane T, Yamamoto A. Modulation of intestinal transport and absorption of Topotecan, a BCRP substrate, by various pharmaceutical excipients and their inhibitory mechanisms of BCRP transporter. J Pharm Sci. 2019;108(3):1315–25.
Homma M, Hirano T, Yuzawa K, Ohkochi N, Kenmochi T. Use trend for generic formulation of immunosuppressive agents: a questionnaire survey for clinical institution in Japan. Organ Boil. 2017;24(1):76–80.
Robertsen I, Åsberg A, Ingerø AO, Vethe NT, Bremer S, Bergan S, Midtvedt K. Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed. Transplantation. 2015;99(3):528–32.
Kimura N, Suzuki A, Sofue S. The bioequivalence between the original and the generic products of mycophenolate mofetil. Jpn Pharmacol Ther. 2015;43(7):945–54.
Crowe A. The influence of P-glycoprotein on morphine transport in Caco-2 cells. Comparison with Paclitaxel. Eur J Pharmacol. 2002;440(1):7–16.
Saeki T, Ueda K, Tanigawara Y, Hori R, Komano T. Human P-glycoprotein transports cyclosporin A and FK506. J Biol Chem. 1993;268(9):6077–80.
Tomita M, Ohkubo R, Hayashi M. Lipopolysaccharide transport system across colonic epithelial cells in normal and infective rat. Drug Metab Pharmacokinet. 2004;19(1):33–40.
Mai Y, Dou L, Murdan S, Basit AW. An animal’s sex influences the effects of the excipient PEG 400 on the intestinal P-gp protein and mRNA levels, which has implications for oral drug absorption. Eur J Pharm Sci. 2018;120:53–60.
Maruyama M, Ishida K, Watanabe Y, Nishikawa M, Takakura Y. Effects of methyl-beta-cyclodextrin treatment on secretion profile of interferon-beta and zonula occuludin-1 architecture in Madin-Darby canine kidney cell monolayers. Biol Pharm Bull. 2009;35:910–5.
Sugibayashi K, Onuki Y, Takayama K. Displacement of tight junction proteins from detergent-resistant membrane domains by treatment with sodium caprate. Eur J Pharm Sci. 2009;36:246–53.
Doi N, Tomita M, Hayashi M. Absorption enhancement effect of acylcarnitines through changes in tight junction protein in Caco-2 cell monolayers. Drug Metab Pharmacokinet. 2011;26:162–70.
Pathak SM, Musmade P, Dengle S, Karthik A, Bhat K, Udupa N. Enhanced oral absorption of saquinavir with methyl-beta-cyclodextrin-preparation and in vitro and in vivo evaluation. Eur J Pharm Sci. 2010;41(3–4):440–51.
Jouan E, Le Vee M, Denizot C, Da Violante G, Ferdel O. The mitochondrial fluorescent dye rhodamine 123 is a high-affinity substrate for organic cation transporters (OCTs) 1 and 2. Fundam Clin Pharmacol. 2014;28(1):65–77.
The authors thank Mr. Yuki Aizawa and Mr. Daisuke Makie for their technical assistance.
This study was supported, in part, by a Grant-in-Aid for Young Scientists (B) (25860127) from the Japan Society for the Promotion of Sciences (JSPS).
Conflict of interest
The authors declare no conflicts of interest.
All animal experiments were performed according to the guidelines of the Tokyo University of Pharmacy and Life Sciences. The study was approved by the Tokyo University of Pharmacy and Life Sciences Committee on the Care and Use of Laboratory Animals (approval number: P12-65 and P13-42).
About this article
Cite this article
Takizawa, Y., Goto, N., Furuya, T. et al. Influene of Pharmaceutical Excipients on the Membrane Transport of a P-glycoprotein Substrate in the Rat Small Intestine. Eur J Drug Metab Pharmacokinet (2020). https://doi.org/10.1007/s13318-020-00631-7